Laurus Labs Ltd

NSE: LAURUSLABS · BSE: 540222 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹2,052.80
Market cap: ₹1,10,915 Cr
Revenue (annual): ₹6,813 Cr
Net profit (annual): ₹888.8 Cr
P/E (TTM): 101.4×Sector 47.4×
Promoter holding: 27.47%-0.02% QoQ
FII holding: 28.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Merger & Restructuring 5 Other Announcement 4 Financial Results 4 Board Meeting Outcome 4 Management Change 3 Results Update 2 Employee Stock Options 2 Dividend 2 Annual General Meeting 2 Results Correction 1 Credit Rating 1 Board Meeting Date 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

28 Apr 2026 11:27 IST NSE

Results Correction

Laurus Labs Results Correction

Laurus Labs Limited clarified deficiencies in its October 23, 2025 financial results submission. The company addressed technical issues regarding machine-readable formats and XBRL discrepancies due to portal glitches. It confirmed that revised and correct XBRL filings have been submitted to the exchange to rectify the inadvertent selection of half-yearly figures.

Read the filing ↗